SCHD's distribution is exactly what it appears to be: dividends received on its stocks, paid through. In FY2025, net investment income of $1.03/share covered the $1.03/share distributed at 1.00× — the payout equals what the portfolio earned, no more.

That coverage is not a one-year fluke. Comparing NII per share to distributions per share across the Financial Highlights, NII has met or exceeded the distribution in every year of FY2021–FY2025:

• NII covered or exceeded the distribution every year. FY2021 $0.76 NII / $0.73 dist (1.04×); FY2022 $0.84 / $0.81 (1.04×); FY2023 $0.91 / $0.87 (1.05×); FY2024 $0.96 / $0.94 (1.02×); FY2025 $1.03 / $1.03 (1.00×). Coverage has narrowed toward 1.00× as the payout has caught up to earnings — worth watching, but still fully earned.
• No return of capital and no capital-gain distribution, six years running. Per SCHD's Statement of Changes in Net Assets, total distributions were paid entirely from net investment income in each of FY2020–FY2025 — a genuinely clean record on this specific point.

What would threaten this income stream is broad dividend cuts among portfolio holdings, or the index screen rotating into lower-yielding names. Neither is currently in evidence.

100% of SCHD's distributions are ordinary dividend income for tax purposes — there is no capital-gain or return-of-capital component in any of the last six fiscal years, per the fund's Statement of Changes in Net Assets. Within that ordinary-income total, the great majority qualifies for the preferential qualified-dividend tax rate.

Per the fund's FY2025 statistics, qualified dividend income was reported as $2,469,946,295 — identical to the fund's total FY2025 distributions of $2,469,946,295 — indicating essentially the entire distribution qualified for the preferential rate that fiscal year. These are fiscal-year figures (SCHD's fiscal year ends August 31), not calendar tax-year figures; a shareholder's actual 1099-DIV for a given tax year reflects a different (calendar-year) measurement window than shown here.

SCHD's valuation question isn't price versus NAV — the creation/redemption mechanism keeps those effectively identical (see Liquidity →). The relevant question is how the current distribution yield compares to the fund's own history, and how the portfolio's fundamentals look.

Two fund-disclosed valuation markers are available from the N-CSR statistics. At 8/31/2025 the fund reported a portfolio price/earnings ratio of 18.0 and price/book of 3.1, with a weighted-average market cap of $136.4B — consistent with a large-cap value-tilted book. The FY2025 distribution yield was 3.7% ($1.03/share ÷ $27.93 year-end NAV). Whether 3.7% is elevated or compressed relative to SCHD's own trailing average requires a continuous daily distribution-yield series, which EDGAR's periodic filings cannot produce.

A precise "current yield relative to trailing average" comparison requires a continuous daily distribution-yield history, which is not derivable from EDGAR's periodic filings alone — the two cells above will populate once a licensed daily feed is connected. A current/live premium-discount is likewise N/A — requires a licensed daily NAV/price feed, not an SEC-disclosed field.

Relative to category peers (other dividend-equity index ETFs), SCHD's 0.06% expense ratio is among the very lowest in the segment. See Manager Quality for peer-level detail.

SCHD holds 100 U.S. large-cap dividend stocks selected by the Dow Jones U.S. Dividend 100 Index. Per the 8/31/2025 holdings schedule, common stocks made up 99.8% of net assets with only 0.2% in short-term money-market holdings. There are no ELNs, no written options, and no credit instruments — the only derivatives are small long stock-index futures (DJIA e-mini and S&P 400 Mid-Cap e-mini) used to equitize cash. The 30% turnover reflects the index's periodic reconstitution.

Because the holdings follow a dividend/quality/yield screen rather than market-cap weights, sector exposure clusters. Per the 8/31/2025 schedule, the largest sectors were Energy (19.8%), Pharmaceuticals/Biotech/Life Sciences (15.7%) and Food/Beverage/Tobacco (15.5%). That is meaningful concentration relative to a broad-market fund, and it is a structural feature of the strategy rather than a temporary tilt.

Concentration read: at 8/31/2025 the single-largest position was Chevron at 4.4% ($3.19B of $72.62B net assets), and the top 10 holdings totaled roughly 34% of net assets — a moderately concentrated book by design. The two largest sectors together (energy + pharma) were about 35.5% of the fund, so cyclical energy and defensive pharma dominate the risk picture more than any single stock.

What the strategy does and doesn't do: the dividend screen produces steady income and a value tilt, but it is not downside protection and it is not diversified across the whole market. In a growth-led rally it will lag (as FY2025 showed); in a value rotation it can lead. It participates fully in broad equity drawdowns.

Schwab Asset Management runs SCHD as a low-cost, rules-based index tracker — the manager's job here is faithful replication and cost control, not stock selection.

On that basis, execution is strong: for FY2025 the fund's NAV return was +2.90% against the Dow Jones U.S. Dividend 100 Index's +2.95% — a five-basis-point gap that is essentially the fund's cost drag, exactly what tight index tracking looks like. The 0.06% expense ratio (reduced from prior periods) is among the lowest in the dividend-ETF category.

The right lens for this fund is not "did it beat the S&P 500" — a dividend-value index structurally can't in a growth-led year, and FY2025's ~13-point lag to the S&P 500 reflects style, not poor management — but "did it track its own index cheaply and cleanly." It did.

Total return here is price appreciation plus distributions, since price tracks NAV closely by construction. The more useful comparison is against the fund's own index (tight) and against its actual peer group of dividend-equity ETFs, below.

ETFs use a creation/redemption mechanism that keeps market price closely aligned with NAV — arbitrage by authorized participants typically closes any gap within minutes. This is a structural feature of the ETF wrapper, not something that depends on a live data feed to describe.

SCHD is one of the largest dividend ETFs in the market: $72.6B net assets and 2.6 billion shares outstanding at 8/31/2025, per its N-CSR. Scale of that magnitude is a strongly favorable liquidity signal — creation/redemption activity was substantial ($24.0B of shares created and $11.6B redeemed in FY2025).

The specific premium/discount, bid-ask spread, and average daily volume figures below require a licensed daily market-data feed — not derivable from EDGAR's periodic filings — and will populate once that feed is connected.

Given the fund's size, transaction costs for a typical retail order are very likely negligible — but the exact spread and volume figures will confirm this once a daily feed is available.